SM
ICPT

Sabby Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sabby Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-447
Closed -$2.61M – 192
2017
Q4 		$2.61M Buy
447
+347
+347% +$21.9K 0.24% 48
2017
Q3 		$580K Buy
+100
New +$10.8K 0.04% 92
2015
Q2 		– Sell
-843
Closed -$23.8M – 371
2015
Q1 		$23.8M Buy
+843
New +$183K 0.99% 22
2014
Q4 		– Sell
-55
Closed -$1.3K – 292
2014
Q3 		$1.3K Sell
55
-13
-19% -$3.31K 0.05% 142
2014
Q2 		$1.61M Buy
+68
New +$17.9K 0.07% 117

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return